Cleared Traditional

K072113 - INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301 (FDA 510(k) Clearance)

Oct 2007
Decision
70d
Days
-
Risk

K072113 is an FDA 510(k) clearance for the INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Integra Lifesciences Corp. (Plainsboro, US). The FDA issued a Cleared decision on October 10, 2007 after a review of 70 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

Submission Details

510(k) Number K072113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2007
Decision Date October 10, 2007
Days to Decision 70 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 132d · This submission: 70d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 24
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K072113.
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026
CollOvine™ Wound Powder
K253140 · Ovigenex, LLC · Feb 2026
Device 104 Particulate
K251323 · Geistlich Pharma AG · Jan 2026
LacertaMatrix
K252673 · Lacerta Life Science · Dec 2025
Theracor
K253339 · Stimlabs, LLC · Dec 2025